Co-Authors
This is a "connection" page, showing publications co-authored by Magnus Gisslén and Karin Welén.
Connection Strength
0.234
-
COVIDENZA - A prospective, multicenter, randomized PHASE II clinical trial of enzalutamide treatment to decrease the morbidity in patients with Corona virus disease 2019 (COVID-19): a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Mar 16; 22(1):209.
Score: 0.234